Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Physical Chemistry Chemical Physics : PCCP|June 4, 2021
Exploring the stability of inhibitor binding to SIK2 using molecular dynamics simulation and binding free energy calculationMingsong Shi, Min Zhao, Lun Wang, et al.
Computational and Structural Biotechnology Journal|June 10, 2022
Molecular dynamics simulations of the conformational plasticity in the active pocket of salt-inducible kinase 2 (SIK2) multi-state binding with bosutinibMingsong Shi, Lun Wang, Kongjun Liu, et al.
Frontiers in Oncology|January 8, 2024
Safety and feasibility of laparoscopic radical resection for bismuth types III and IV hilar cholangiocarcinoma: a single-center experience from ChinaJianjun Wang, Yang Xia, Yuan Cao, et al.
ACS Omega|September 19, 2022
Molecular Docking, Molecular Dynamics Simulations, and Free Energy Calculation Insights into the Binding Mechanism between VS-4718 and Focal Adhesion KinaseMingsong Shi, Tao Chen, Siping Wei, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 9, 2025
Preclinical evaluation of <sup>89</sup>Zr/<sup>177</sup>Lu-labelled anti-B7-H3 monoclonal antibody for theranostics in B7-H3-positive liver cancerYuanyuan Liang, Tao Wu, Zhou Lu, et al.
Frontiers in Genetics|July 12, 2024
Lactylation: The emerging frontier in post-translational modificationZhou Lu, Xueting Zheng, Mingsong Shi, et al.
Journal of Biological Engineering|April 27, 2023
Novel organoid construction strategy for non-involuting congenital hemangioma for drug validationHaoche Wei, Yanan Li, Li Li, et al.
International Journal of Pharmaceutics|November 14, 2024
Preclinical evaluation of <sup>89</sup>Zr/<sup>177</sup>Lu-labeled amatuximab for theranostic application in pancreatic ductal adenocarcinomaZhou Lu, Mingsong Shi, Xueting Zheng, et al.
European Journal of Medicinal Chemistry|May 13, 2023
Discovery of pyrimidine-5-carboxamide derivatives as novel salt-inducible kinases (SIKs) inhibitors for inflammatory bowel disease (IBD) treatmentXiaoying Cai, Lun Wang, Yuyao Yi, et al.
Frontiers in Pharmacology|May 26, 2023
Identification of abemaciclib derivatives targeting cyclin-dependent kinase 4 and 6 using molecular dynamics, binding free energy calculation, synthesis, and pharmacological evaluationYanting Zhou, Xiandeng Li, Peifang Luo, et al.
Pageof 5